FR2434622A1 - AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS - Google Patents

AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS

Info

Publication number
FR2434622A1
FR2434622A1 FR7921975A FR7921975A FR2434622A1 FR 2434622 A1 FR2434622 A1 FR 2434622A1 FR 7921975 A FR7921975 A FR 7921975A FR 7921975 A FR7921975 A FR 7921975A FR 2434622 A1 FR2434622 A1 FR 2434622A1
Authority
FR
France
Prior art keywords
cancer patients
feeding
amino acid
acid solutions
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7921975A
Other languages
French (fr)
Other versions
FR2434622B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2434622A1 publication Critical patent/FR2434622A1/en
Application granted granted Critical
Publication of FR2434622B1 publication Critical patent/FR2434622B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

La présente invention est relative à des solutions d'acides aminé. Ces solutions contiennent (pour un litre) : 1,4-14,0 g de leucine, 1,4.10,0 g de valine, 1,6-10,0 g d'isoleucine, 1,5-14,9 g de lysine, 1,0-9,4 g de phénylalanine, 1,0-6,7 g de thréonine et 0,4-4,0 g de tryptophane. Elles ne contiennent pas de méthionine. Application au traitement des patients atteints de cancer.The present invention relates to solutions of amino acids. These solutions contain (for one liter): 1.4-14.0 g of leucine, 1.4.10.0 g of valine, 1.6-10.0 g of isoleucine, 1.5-14.9 g of lysine, 1.0-9.4 g of phenylalanine, 1.0-6.7 g of threonine and 0.4-4.0 g of tryptophan. They do not contain methionine. Application to the treatment of cancer patients.

FR7921975A 1978-09-04 1979-09-03 AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS Granted FR2434622A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
FR2434622A1 true FR2434622A1 (en) 1980-03-28
FR2434622B1 FR2434622B1 (en) 1983-04-15

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921975A Granted FR2434622A1 (en) 1978-09-04 1979-09-03 AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS

Country Status (10)

Country Link
JP (1) JPS5535049A (en)
AU (1) AU526207B2 (en)
CA (1) CA1134275A (en)
CH (1) CH642541A5 (en)
DE (1) DE2935709C2 (en)
FR (1) FR2434622A1 (en)
GB (1) GB2029220B (en)
IT (1) IT1194844B (en)
NL (1) NL190266C (en)
SE (1) SE448679B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (en) * 1985-12-19 1987-06-26 Centre Nat Rech Scient METHIONINE-DEFECTED NUTRITIONAL COMPOSITIONS FOR INHIBITING THE DEVELOPMENT AND DISSEMINATION OF MALIGNANT TUMORS IN MAMMALS

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500526A (en) * 1981-04-17 1983-04-07 アメリカン　ホスピタル　サプライ　コ−ポレ−シヨン Improved solutions for parenteral nutrition
FR2508797B1 (en) * 1981-07-03 1986-03-14 Charles Chany MEDICINAL PRODUCT COMPRISING THE REACTION OF A C1 TO C6 CARBOXYLIC ACID ON A BASIC AMINO ACID
DE3329253A1 (en) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Use of an amino acid mixture for the control of, in particular, lymphadenomas
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (en) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell MEDICINAL SOLUTION CONTAINING AMINOSAUR SOLUTIONS FOR THE TREATMENT OF CANCER DISEASES AND METHOD FOR THE PRODUCTION THEREOF
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
TW394686B (en) * 1991-10-07 2000-06-21 Otsukapharmaceutical Co Ltd An enteral feeding nutritional composition having anticancer effects
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (en) * 1992-08-29 1994-03-03 Wella Ag Hair setting agent based on lignin or lignin derivatives and dihydroxypropyllignin
ES2184756T3 (en) * 1992-11-19 2003-04-16 Anticancer Inc USE OF METIONINASE AS AN ANTITUMORAL AGENT IN ANTIMETIONINE CHEMOTHERAPY.
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
EP0921794A1 (en) * 1996-07-30 1999-06-16 Novartis Nutrition AG Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
EP1163904B1 (en) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium
EP1195159B1 (en) * 2000-10-09 2006-05-31 Rath, Matthias, Dr. med. Therapeutic combination of ascorbate with lysine and arginine for prevention and treatment of cancer
CH694549A5 (en) 2001-01-16 2005-03-31 Dr Matthias Rath A composition comprising an ascorbate and a fibrinolysis inhibitor for treating diseases associated with extracellular matrix degradation e.g. arteriosclerosis, cancer, inflammations and infections
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (en) * 2001-10-05 2003-04-17 Tetsuro Asao Immune system activators
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2005092097A1 (en) * 2004-03-19 2005-10-06 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
US8580750B2 (en) * 2005-07-29 2013-11-12 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2007016955A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Alcohol metabolism moderating composition
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
PL2156188T3 (en) 2007-03-28 2021-11-15 University Of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
CA3045883C (en) * 2008-04-24 2022-06-28 University Of Southern California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
JP6090836B2 (en) * 2011-02-17 2017-03-08 Ｅａファーマ株式会社 Anti-tumor activity enhancer of chemotherapeutic agent
JP2016117702A (en) * 2014-12-22 2016-06-30 武輝 山田 Method for destroying cancer cells
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000000454A1 (en) * 2020-01-13 2021-07-13 Professional Dietetics Spa COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (en) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (en) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Amino acid mixts. for treating kidney and liver disorders - with reduced methionine and phenylalanine content

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU423304A3 (en) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2531204A1 (en) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (en) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (en) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Amino acid mixts. for treating kidney and liver disorders - with reduced methionine and phenylalanine content

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1959 *
CA1970 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (en) * 1985-12-19 1987-06-26 Centre Nat Rech Scient METHIONINE-DEFECTED NUTRITIONAL COMPOSITIONS FOR INHIBITING THE DEVELOPMENT AND DISSEMINATION OF MALIGNANT TUMORS IN MAMMALS
WO1987003810A1 (en) * 1985-12-19 1987-07-02 Centre National De La Recherche Scientifique (Cnrs Nutrient compositions deprived of methionine and supplemented with homocysteine
EP0232652A1 (en) * 1985-12-19 1987-08-19 Centre National De La Recherche Scientifique (Cnrs) Methionine-deficient nutritional compositions containing supplementary homocysteine

Also Published As

Publication number Publication date
GB2029220A (en) 1980-03-19
IT1194844B (en) 1988-09-28
IT7905216A0 (en) 1979-09-03
SE7907316L (en) 1980-03-05
SE448679B (en) 1987-03-16
NL190266C (en) 1994-01-03
AU5036879A (en) 1980-03-13
AU526207B2 (en) 1982-12-23
FR2434622B1 (en) 1983-04-15
CH642541A5 (en) 1984-04-30
NL190266B (en) 1993-08-02
DE2935709C2 (en) 1986-02-06
CA1134275A (en) 1982-10-26
JPS5535049A (en) 1980-03-11
JPS6154007B2 (en) 1986-11-20
NL7906620A (en) 1980-03-06
DE2935709A1 (en) 1980-03-13
GB2029220B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
FR2434622A1 (en) AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS
ATE213389T1 (en) ANTEMORTEM FEED SUPPLEMENT FOR LIVE CATTLE
BE1002296A5 (en) PEPTIDE DERIVATIVES.
EP0751769A4 (en) Medical treatment using thyroid hormones
GB1511302A (en) Pharmaceutical compositions comprising amino acid analogues
BR9104997A (en) COMPLEXES CONNECTED TO HYDROGEN BRIDGE, PROCESS FOR ITS PHARMACEUTICAL PREPARATION
GR852541B (en)
KR930002373A (en) Hexapeptide
ATE3416T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES AND MEDICATIONS CONTAINING THEM.
ES2072244T1 (en) REACTION COMPOUNDS AND PRODUCTS OF AMADORI, PROCEDURE FOR THEIR MANUFACTURE AND USE THEREOF.
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
ES2160595T3 (en) TREATMENT OF HEPATOMAS WITH SOMATOSTATINE ANALOGS.
IT1250636B (en) SALT OF DICLOFENAC, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
MA20303A1 (en) Nutritional composition containing alpha-cetoisocaproic acid, leucine and essential and non-essential amino acids.
Gambert et al. Thyroid hormone regulation of central nervous system (CNS) beta-endorphin and ACTH
IL88726A0 (en) Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
ATE92078T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
JPS5668374A (en) Food composition for hepatic insufficiency
CA2099529A1 (en) Antemortem nutrient supplement for livestock
ATE70454T1 (en) PRODUCT CONTAINING VINCRISTIN.
KAPLAY et al. Regulation of tRNA methylase by thyroxine in rat liver
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
DK0423326T3 (en) Hitherto unknown physiologically active peptide and calcium metabolism regulator comprising the peptide as effective organism
GB955683A (en) Pharmaceutical cobalamin compositions
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids